
|Articles|December 1, 2012
Good prostate cancer outcomes possible with LN-positive disease
Good long-term cancer-specific outcome is possible in well-selected prostate cancer patients found to have lymph node-positive disease at radical prostatectomy, findings from analyses based on 30 years of experience at a single institution demonstrate.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
2
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
3
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
4
The UroOnc Minute: Variant Histologies in Bladder Cancer, With Carissa Chu, MD
5











